Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model

被引:0
作者
Manoglu, Berke [1 ]
Yavuzsen, Tugba [2 ]
Aktas, Safiye [3 ]
Altun, Zekiye [3 ]
Yilmaz, Osman [4 ]
Gokbayrak, Ozde Elif [3 ]
Erol, Aylin [3 ]
机构
[1] Dokuz Eylul Univ, Dept Gen Surg, Sch Med, Izmir, Turkiye
[2] Dokuz Eylul Univ, Dept Clin Oncol, Fac Med, Izmir, Turkiye
[3] Dokuz Eylul Univ, Dept Basic Oncol, Inst Oncol, Izmir, Turkiye
[4] Dokuz Eylul Univ, Dept Lab Anim Sci, Fac Med, Izmir, Turkiye
关键词
colorectal cancer; hyperthermic intraperitoneal chemotherapy (HIPEC); peritoneal metastasis model; CARCINOMATOSIS; CANCER; MALIGNANCIES; THERAPY;
D O I
10.1515/pp-2023-0002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: In our study, we aimed to (1) create a peritoneal metastasis (PM) model in nude mice, administer intraperitoneal chemotherapy using the peritoneal infusion pump we developed in this model, and (2) compare the efficacy of intraperitoneal chemotherapy using various drugs at different temperatures.Methods: The peritoneal metastasis model was established in nude mice using the CC531 colon carcinoma cell line. Models with peritoneal metastasis (PM) were randomized into four groups of seven animals each: Group 1, control group (n=7); Group 2, normothermic intraperitoneal chemotherapy (NIPEC) with mitomycin C(MMC) (n=7); Group 3, hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C (n=7), and Group 4, NIPEC with 5-fluorouracil (5-FU).Results: Tumor development was achieved in all animals. While the tumor burden decreased significantly in the treatment Group 3 (p=0.034), no significant difference was found in the other groups. In the PM mouse model, hyperthermic intraperitoneal administration of MMC had the highest tumoricidal effect.Conclusions: Our PM model provided a good opportunity to examine the efficacy of HIPEC and intraperitoneal infusion pump (IPIP). In future studies, we plan to evaluate efficacies of different drugs in the PM models we have created.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 50 条
  • [41] Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands
    Razenberg, L. G. E. M.
    van Gestel, Y. R. B. M.
    Creemers, G. -J.
    Verwaal, V. J.
    Lemmens, V. E. P. P.
    de Hingh, I. H. J. T.
    EJSO, 2015, 41 (04): : 466 - 471
  • [42] The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Wong, Jolene Si Min
    Tan, Grace Hwei Ching
    Chia, Claramae Shulyn
    Ong, Johnny
    Ng, Wai Yee
    Teo, Melissa Ching Ching
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [43] Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model
    Klaver, Y. L. B.
    Hendriks, T.
    Lomme, R. M. L. M.
    Rutten, H. J. T.
    Bleichrodt, R. P.
    de Hingh, I. H. J. T.
    BRITISH JOURNAL OF SURGERY, 2010, 97 (12) : 1874 - 1880
  • [44] Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis
    Sun, Tuanhe
    Li, Kang
    Xu, Gang
    Zhu, Kun
    Wang, Qiong
    Dang, Chengxue
    Yuan, Dawei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [45] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
    Rosa, Fausto
    Galiandro, Federica
    Ricci, Riccardo
    Di Miceli, Dario
    Quero, Giuseppe
    Fiorillo, Claudio
    Cina, Caterina
    Alfieri, Sergio
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (08) : 2797 - 2805
  • [46] Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
    Mangieri, Christopher W.
    Levine, Edward A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
    Dietz, Michelle V.
    Hannink, Gerjon
    Said, Ibrahim
    van der Zant, Femke A.
    van de Vlasakker, Vincent C. J.
    Brandt-Kerkhof, Alexandra R. M.
    Verhoef, Cornelis
    Bremers, Andreas J. A.
    de Wilt, Johannes H. W.
    Hemmer, Patrick H. J.
    de Hingh, Ignace H. J. T.
    de Reuver, Philip R.
    Madsen, Eva V. E.
    EJSO, 2024, 50 (06):
  • [48] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A pragmatic comparison of oncological outcomes in synchronous versus metachronous disease
    Aguirre-Allende, Ignacio
    Pereira-Perez, Fernando
    Manzanedo-Romero, Israel
    Fernandez-Briones, Paula
    Munoz-Martin, Maria
    Serrano-Moral, Angel
    Perez-Viejo, Estibalitz
    SURGICAL ONCOLOGY-OXFORD, 2025, 58
  • [49] An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer
    Liu, Duo
    Chen, Zexin
    Deng, Weihao
    Lan, Jianqiang
    Zhu, Yu
    Wang, Huaiming
    Xu, Xing
    Zhang, Yuanxin
    Wu, Xiangwei
    Yang, Keli
    Cai, Jian
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (03) : 1925 - 1940
  • [50] Perioperative and Oncological Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Rectal Origin
    Benvenisti, Haggai
    Shiber, Mai
    Assaf, Dan
    Shovman, Yehuda
    Laks, Shachar
    Elbaz, Nadav
    Mor, Eyal
    Zippel, Douglas
    Nissan, Aviram
    Ben-Yaacov, Almog
    Adileh, Mohammad
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (11) : 2506 - 2514